1. Medtech Insight
  2. >>Business

Integra LifeSciences Returns To Organic Growth After Rough Year With COVID-19

 
• By Barnaby Pickering

Integra's first-quarter revenue was up less than 3%, year over year, but the company reported the integration of the ACell regenerative technology business is ahead of schedule

Earning Report Q1

Integra LifeSciences reported revenue of $360.1m in the first quarter of 2021 – up 2.9% year over year on an organic basis – driven by sales in Asia. 

The ACell regenerative technology business, which the company acquired in January, contributed $14.1m during the quarter. Integra CEO Peter Arduini said during the April 28 earnings call that the company’s first quarter sales were “in line with expectations” and that Integra had completed the commercial integration of ACell ahead of Schedule

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

FDA Announces Classifications On 8 Device Types

 
• By Elizabeth Orr

The US Food and Drug Administration has announced new classifications for eight device types that reached market via the de novo process, with most of the newly classified products in the diagnostics sector.

Medical Devices Not The Focus Of FDA’s Plans To Step Up Foreign Inspections, Expert Says

 
• By Brian Bossetta

The US FDA recently announced plans to carry out more unannounced inspections of foreign facilities. But those inspections will primarily target drug producers, with less attention and resources allocated to those making devices.

State And International Enforcement Agencies May Step Up Amid Uncertain Federal Environment

 
• By Elizabeth Orr

States and international regulatory bodies may increase their US enforcement role following federal staff cuts, Hyman Phelps & McNamara attorneys said in a recent webinar. The attorneys also expect False Claims Act enforcement and public health to remain key areas of focus at the federal level.